Navigation Links
Organovo Reports 2012 Financial Results
Date:3/18/2013

SAN DIEGO, March 18, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has reported on its financial results for the year ended December 31, 2012.  The Company also reported on its corporate highlights during fiscal 2012.

2012 Corporate Highlights

  • Closed  $24.6 million in equity financings associated with the Company's go-public reverse merger;
  • Recorded $1.2 million in revenue, representing a twenty percent (20%) increase over the prior year
  • Received multiple issued patents, including the Company's first assigned patent, and licensed an additional issued patent
  • Formed a partnership with Autodesk Research to develop 3D bioprinting software
  • Joined QX tier of the OTC Markets
  • Moved to a new larger research and headquarters facility
  • Expanded executive management with the addition of Dr. Eric David as Chief Strategic Officer and Michael Renard as Chief Commercial Officer
  • Appointed an additional independent director to serve as Audit Committee Chairman
  • Reduced its warrant liability by $23.3 million
  • Named in  TR50Technology Review's annual list of the world's most innovative technology companies
  • Featured in Wall Street Journal
  • "Organovo successfully went public, grew substantially, and raised significant financing in 2012," stated Keith Murphy, chief executive officer of Organovo. "We continue to attract great partners and see tremendous scientific results from our bioprinting efforts.  We look forward to continued success in 2013 as we seek to continue to provide long-term shareholder value."

    Financial ResultsRevenues
    2012 total revenues of $1.2 million, representing an inc
    '/>"/>

    SOURCE Organovo Holdings, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
    2. Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research
    3. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
    4. Organovo Reports Q2 2012 Financial Results, Provides Business Update
    5. Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
    6. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
    7. Organovo Holdings Appoints James T. Glover to Board of Directors
    8. China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012
    9. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
    10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
    11. Addus HomeCare Reports Fourth Quarter 2012 Results Completes Sale of Home Health Assets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... 2014  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today that ... Officer, has been elected to the Company,s Board of ... G. Anderson , Executive Chairman of CryoLife, stated, "Since joining ... an excellent leader who is well positioned to maximize ...
    (Date:10/22/2014)... October 22, 2014 Oramed ... a clinical-stage pharmaceutical company focused on the development ... top-line clinical results from its Phase IIa clinical ... capsules, to treat type 1 diabetes. The trial was ... under a U.S. Food and Drug Administration ...
    (Date:10/22/2014)... Oct. 21, 2014  Early symptoms of diabetic ... unnoticed, but new technology, coupled with yearly, comprehensive ... to earlier detection of eye diseases, including those ... Americans. If left untreated, these diseases can potentially ... Recently, optometric researchers have deployed a ...
    Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
    ... NEWS, Va., March 31, 2011 The U.S. Department ... story in the field of medical technology and innovation ... to the government agency, Dilon and similar entrepreneurs, "build ... solve some of our toughest global challenges." ...
    ... and MUNICH, March 31, 2011 Advanced Cell ... and Definiens, a leading provider for biomedical image ... to develop image analysis applications that will enable ... individual cells in routine clinical specimen. The partnership ...
    Cached Medicine Technology:U.S. Department of Energy Hails Dilon Diagnostics as a Medical Technology Pioneer and Top National Innovator 2Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis 2Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis 3
    (Date:10/22/2014)... With the Affordable Care Act (ACA) open enrollment period starting ... Research (AIR) finds that three out of four Americans are ... percent say they are not likely or only somewhat likely ... , The AIR survey found wide gaps in Americans’ health ... how much they owe for a routine doctor’s visit. , ...
    (Date:10/22/2014)... 22, 2014 Healthcare professionals who ... continuing education at home or on-the-go via laptops, ... 20 brand new, premium Seminar-on-Demand CE courses. The ... over 2,000 hours of CE course ... educational experience. With such a diverse library, there’s ...
    (Date:10/22/2014)... 2014 Lintelus, Inc., an event software ... of Sales, will be speaking on the subject of ... on October 28, at the Holiday Inn in New ... as well as a Tech Demo at 12:45pm, to ... a more engaging event experience. , The Annual Meetings ...
    (Date:10/22/2014)... Steven Reinberg HealthDay Reporter , ... add weight and length may be showing a genetic propensity ... adults, certain genes have been linked to increased body fat, ... fat and lean muscle, the researchers said. At 1 ... By ages 2 and 3, however, these genes were linked ...
    (Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... lead to increased blood pressure, according to a new study. ... blood pressure for young adult women or for teenagers, according ... lightly or moderately, their risk of high blood pressure was ... studies in older adult men and women," said lead researcher ...
    Breaking Medicine News(10 mins):Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4
    ... PARK, Ill., March 4 Abbott will present at ... on Tuesday, March 17. Thomas C. Freyman, executive ... a formal presentation on the company at 8:30 a.m. ... be accessible through Abbott,s Investor Relations Web site at ...
    ... BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader ... today announced that on or before March 16, 2009 ... for the Southern District of New York, its response ... investors, Longview Special Finance, Inc. and Longview Fund, L.P. ...
    ... , , WEDNESDAY, March 4 (HealthDay News) -- Scientists report ... HIV-like virus in five female monkeys, an encouraging sign ... research is still in its early stages. However, the ... into sexual lubricants that women could use to avoid ...
    ... Verathon(R) is pleased to announce the new BladderScan(R) ... to help physicians identify the presence of abdominal ... the BladderScan(R) BVI 9000 series will make its ... in Rosemont, IL on March 5. (Verathon Booth ...
    ... (NYSE: CVS ) today announced that its ... $0.07625 per share on the Common Stock of the ... on April 22, 2009.(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO )About CVS ... the nation. The Company fills or manages more than ...
    ... 04, 2009 A new study appearing in Journal ... women who reported taking daily naps had a significantly greater ... contrast to a number of prior studies which have indicated ... 8,101 Caucasian women aged 69 and older were studied over ...
    Cached Medicine News:Health News:BIO-key to Respond in Court to a Lawsuit Filed by Two Investors 2Health News:BIO-key to Respond in Court to a Lawsuit Filed by Two Investors 3Health News:Germicide Might Guard Against HIV Infection 2Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 2Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 3Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 4
    ... sophisticated whole blood analysis system that is ... satisfying the stringent requirements of the central ... all of the components of a traditional ... sampling unit, all of the sensors and ...
    248 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
    Microcomputer controlled, preparative ultracentrifuge, with CFC-free refrigeration system. Available either internally cooled or with external water cooling. Quikset user interface, Softspin automati...
    ... The optimal combination of performance and ... 4x5 mL swinging bucket rotor. DiscoveryTMM120 ... ml to 8.3 ml, with a ... very quiet operation, rotor imbalance detection, ...
    Medicine Products: